IRadimed Corporation
Market Cap
$1.31B
P/E Ratio
58.74
EPS
$1.75
Dividend Yield
1.22%
52-Week Range
$47.48 — $107.90
Volume
68.23K
Avg Volume
72.26K
Beta
1.10
P/E (TTM)
58.74
Forward P/E
49.42
PEG Ratio
9.36
P/S (TTM)
15.02
P/B (TTM)
13.32
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.24%
ROA (TTM)
0.21%
ROIC
—
Gross Margin
0.77%
Operating Margin
0.31%
Net Margin
—
Debt/Equity
0.00
Current Ratio
7.98
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.21%
EPS Growth (5Y)
+1.37%
Sales Growth (3Y)
+0.16%
Sales Growth (5Y)
+0.22%
EPS Est (This Year)
$2.08
EPS Est (Next Year)
$2.32
Dividend Yield
—
Annual Dividend
$0.50
Payout Ratio
—
Frequency
—
Ex-Dividend Date
2025-12-17
Cash/Share
$4.02
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
12.72M
Float
7.38M
Free Float %
58.05%
RSI (14)
54.02
SMA 20
$99.68
SMA 50
$97.71
SMA 200
$78.10
ATR (14)
3.70
Volatility (Week)
0.05%
Volatility (Month)
0.03%
Pattern
—
1 Day
+9.57%
1 Week
+7.32%
1 Month
+6.27%
3 Months
+24.69%
6 Months
+50.21%
1 Year
—
YTD
+10.10%
All-Time High
$107.90
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2014-07-16
Employees
160
CEO
Roger E. Susi
Index Membership
—
Website
https://www.iradimed.com
IRadimed Corporation (IRMD) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $1.31B, a P/E ratio of 58.74, and a dividend yield of 1.22%, IRMD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IRMD against other stocks using dozens of fundamental and technical filters.
IRadimed Corporation (IRMD) has a trailing twelve-month (TTM) P/E ratio of 58.74. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, IRadimed Corporation (IRMD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
IRadimed Corporation (IRMD) has a market capitalization of $1.31 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
IRadimed Corporation (IRMD) has returned +10.10% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.